Abstract
Patients with bulky testicular cancer have a complete response (CR) rate from 20 to 50%.[1] The optimal timing of cytoreductive surgery has been an area of frequent debate. Data from Javadpour et al.,[1] based on a prospective randomized trial suggest that cyto-reductive surgery prior to chemotherapy is not indicated in patients with advanced testicular cancer. The question arises as to whether the optimal induction therapy should be nonintensive or intensive. The present study was undertaken to evaluate the efficacy of two different nonintensive chemotherapeutic regimens and to examine how pretreatment factors may affect complete remission rates, duration of remission, and survival.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
N. Javadpour, R. F. Ozols, A. Barlock, T. Anderson, and R. C. Young, A randomized trial of cytoreductive surgery followed by chemotherapy chemotherapy alone in bulky stage III,Cancer 50: 2004–2010 (1981).
A. W. Silverman, Surgical debulking of tumors,Surg.Gynecol.Obst., 155:577–585 (1982).
D. G. Skinner, Advanced metastatic testicular cancer: The need for reporting results according to initial extent of disease,J.Urol., 128: 312–314 (1982).
WHO Handbook for reporting results of cancer treatment WHO offset Publication No 48 Geneva, (1979).
L. H. Einhorn, ans S. D. Williams, Chemotherapy of disseminated testicular cancer. A random prospective study,Cancer, 46:1339–1344 (1980).
R. F. Ozols, A. B. Deisseroth, N. Javadpour, A. Barlock, G. L. Meserschmidt, ans R. C. Young, Treatment of Poor Prognosis Nonseminomatous Testicular Cancer with a “high dose” platinum combination chemotherapy regimen, Cancer, 51:1803–1807(1983).
N. Jaeger, L. Weiβbach, J. E. Altwein, and E. D. Kreuser, Primary lymphadenectomy or primary chemotherapy in bulky tumor and disseminated cancer, Europ.Urol., 1983 (in press).
L. H. Einhorn, S. Williams, J. Mandelbaum, and J. P. Einhorn, Surgical resection in disseminated testicular cancer following chemotherapeutic cytoreductivn, Cancer, 48:904–908 (1981).
J. P. Donohue, L. H. Einhorn, ans S. Williams, Cytoreductive surgery for metastatic testicular cancer: considerations of timing and extent, J.Urol., 123:879–879 (1979).
D. Vugrin, W. F. Whitmore, P. Sogani, M. Bains, H. W. Herr, and R. Golbey, Combined chemotherapy and surgery in treatment of advanced germ-cell tumors, Cancer, 47:2228–2231 (1981).
C. Merrin, H. Tatzita, R. Weber, Z. Wajsman, G. Baumgartner, and G. P. Murphy, Combination radical surgery and multiple sequential chemotherapy for the treatment of advanced carcinoma of the testis (Stage III), Cancer, 37: 20–29 (1976).
T. Anderson, T. A. Waldmann, N. Javadpour, and E. Glatstein, Testicular germ-cell neoplasms: Recent advances in prognosis and therapy Ann.Intern.Med., 90:373–385 (1979).
M. K. Samson, R. Fisher, and R. L. Stephens, Vinb lastine, bleomycin and desdiamminedichloroplatinum in dissemiated testicular cancer: Response to treatment and prognosis correlations, Eur.J.Cancer, 46:1359–1366 (1981).
R. W. Sonntag, H. J. Senn, and F. Cavalli, Treatment of metastatic testicular cancer A preliminary report of induction chemotherapy followed by maintenance chemotherapy or radio¬therapy, Cancer Treat.Rep., 63:1669–1674 (1979).
J. A. Levi, R. S. Armey, and D. N. Dalley, Significant factors in the optimal management of advanced stage germ cell carci¬noma Aust.N.Z.J.Med., 12:147–152 (1982).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Plenum Press, New York
About this chapter
Cite this chapter
Altwein, J.E., Kreuser, E., Jaeger, N., Weißbach, L., Schreml, W. (1985). Combined Chemotherapy and Surgery in treatment of Bulky Germ-Cell Tumors: Comparison of Two Induction Regimens and Evaluation of Poor Prognostic Factors. In: Pavone-Macaluso, M., Smith, P.H., Bagshaw, M.A. (eds) Testicular Cancer and Other Tumors of the Genitourinary Tract. Ettore Majorana International Science Series, vol 8. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2453-9_18
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2453-9_18
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9490-0
Online ISBN: 978-1-4613-2453-9
eBook Packages: Springer Book Archive